MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2011-12-15
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 500
- Registration Number
- NCT00170001
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients
Phase 3
Completed
- Conditions
- Heart Transplantation
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-01-28
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 6
- Registration Number
- NCT00169936
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Posturing Effects on Perception of Time and Perceptions of the Provider-Patient Interaction in the Emergency Department
Completed
- Conditions
- Healthy
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-02-02
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 244
- Registration Number
- NCT00170105
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Precision of the Magnetocardiographer for Data Aquision and Analysis.
Phase 3
Completed
- Conditions
- Myocardial Ischemia
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2011-02-15
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 12
- Registration Number
- NCT00170014
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Effects of Motivational Interviewing on Self-Efficacy and Standardized Low Back Pain Outcomes in Patients With Chronic Back Pain"
Not Applicable
Completed
- Conditions
- Chronic Low Back Pain
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-01-28
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 6
- Registration Number
- NCT00170118
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
Phase 2
Completed
- Conditions
- Stage III Prostate CancerProstate AdenocarcinomaStage IV Prostate CancerProstate CarcinomaRecurrent Prostate Carcinoma
- Interventions
- Other: Pharmacological Study
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 112
- Registration Number
- NCT00170157
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.
Phase 4
Completed
- Conditions
- Heart Valve Diseases
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2008-07-24
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT00166400
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent
Not Applicable
Completed
- Conditions
- Ureteral Obstruction
- Interventions
- Device: JJ StentDevice: Memokath 051 Ureteral Stent
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2014-07-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 29
- Registration Number
- NCT00166361
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation
Phase 2
Completed
- Conditions
- Transplantation, Liver
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-05-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT00166556
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-05-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 38
- Registration Number
- NCT00166413
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath